Coagulation Market Size and Forecasts (2020-2030)

Coagulation Market Size and Forecasts (2020-2030)

Coagulation Market Size and Forecasts (2020 – 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von Willebrand’s Disease, and Others), Type [Clinical Laboratory Analyzers (Controls & Calibrators, Assays & Reagents, Instruments/Systems, Coagulation Factors, and Others) and Point-of-Care Testing Analyzers], Offering [Diagnosis (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimmer Testing, Platelets Function Testing, and Others) and Treatment (Anti-Fibrinolytic Drugs, Birth Control Pills, Desmopressin & Immunosuppressive Medicines, Vitamin K Supplements, Blood Thinners, Thrombin Inhibitors or Thrombolytics, Replacement Therapy, Catheter-Assisted Thrombus Removal, and Others)], Technology (Optical Technology, Mechanical Technology, Electrochemical Technology, and Others), End User (Clinical Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)

Send Enquiry
Item ID: TIPRE00030085 Category: Tag:

$3,185 – $5,985

Description

The coagulation market is expected to grow from US$ 6.295 billion in 2022 to US$ 10.853 billion by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030.

Changing lifestyle habits and a growing geriatric population are among the major factors increasing the prevalence of blood disorders. Therefore, there is a growing demand for early diagnosis and treatment. Key players are taking several initiatives through various organic and inorganic strategies to enhance the quality of life of patient population.

• In July 2020, Sysmex Corporation launched the Automated Blood Coagulation Analyzers CN-6500/CN-3500 in Japan. The analyzer measures blood coagulation and platelet aggregation parameters, as well as thrombosis and hemostasis parameters.

• In April 2020, US-based Haemonetics Corporation acquired Enicor, a blood coagulation diagnostic system developer.

• In October 2021, Trivitron Healthcare launched a new line of coagulation analyzer products manufactured by Diagon Ltd in India.

• In June 2021, Trivitron Healthcare introduced NANO H5 and NANO H110, which help in monitoring diabetes, hemoglobin variations, and thalassemia.

• In February 2021, Siemens Healthineers and Sysmex Corporation renewed their agreement to supply, distribute, sell, and service hemostasis products across the world. The agreement also included an extension for multiple years. Further, Siemens Healthineers agreed to distribute Sysmex’s automated blood coagulation analyzer, such as the CN-3000 and CN-6000.

• In July 2022, HORIBA Medical launched the latest Yumizen G800 and G1550 hemostasis analyzers, as well as a range of convenient ready-to-use reagents for common blood coagulation tests. With this expansion of its product line, HORIBA Medical now offers a comprehensive selection of hemostasis systems and advanced reagents for laboratories of all sizes and requirements.

Thus, the adoption of various organic and inorganic strategies by the key market players is expected to provide opportunities for the coagulation market growth during the forecast period.

Rising Prevalence of Cardiovascular Diseases drives the growth the Coagulation Market

Heart disease is one of the leading causes of hospitalization, death, and reduced physical performance due to conditions such as atrial fibrillation and stroke. It affects the hemostatic system, vascular system, and fluid dynamics of blood and causes arterial and venous thrombosis. Thrombosis is the leading cause of death and complications from cardiovascular disease. Blood vessels damaged by smoking and high blood pressure form cholesterol-rich plaques lining the blood vessels, which can rupture and cause platelets to clot. With coagulation disorders, there is a risk of myocardial infarction, stroke, and atherothrombotic events in the vascular beds. Heart failure (HF) is related to an increased risk of thromboembolism independent of the presence of atrial fibrillation (AF). Platelet activation and coagulation system abnormalities can increase the risk of serious thromboembolic events in patients suffering from HF.

According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, ~119.1 million deaths due to CVDs and around 89.1 million and 68.2 million stroke and ischemic stroke cases, respectively, are recorded across the world in 2020. Per the National Center for Chronic Disease Prevention and Health Promotion, in 2023, the US reports ~877,500 deaths due to heart diseases every year. According to the American Heart Association, more than 130 million Americans are likely to acquire some form of CVD by 2035. As per ‘Global Burden of Disease Study 2019,’ CVDs were the leading cause of deaths in Asia Pacific in 2019, causing 10.8 million or 35% of the total fatalities.

A coagulation test helps prevent potential heart attack-causing blood clotting. A coagulation analyzer is used during coronary artery bypass surgery and angioplasty to monitor information on blood clotting status. Thus, the growing incidence of cardiovascular diseases bolsters the coagulation market growth.

The coagulation market is segmented on the basis of disease indication, type, offering, technology, end user, and geography. Based on disease indication, the coagulation market is segmented into vitamin K deficiency, liver disease, disseminated intravascular coagulation & pulmonary embolism, circulating anticoagulant development, hemophilia, von Willebrand’s disease, and others. Based on type, the coagulation market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. Clinical laboratory analyzers consist of controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others. Based on offering, the coagulation market is segmented into diagnosis and treatment. The diagnosis segment is further classified into prothrombin time testing, fibrinogen testing, activated clotting time testing, activated partial thromboplastin time testing, D-dimmer testing, platelets function testing, and others. The treatment segment is further classified into anti-fibrinolytic drugs, birth control pills, desmopressin & immunosuppressive medicines, vitamin K supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapies, catheter-assisted thrombus removal, and others. Based on technology, the coagulation market is segmented into optical technology, mechanical technology, electrochemical technology, and others. Based on end user, the coagulation market is segmented into clinical laboratories, hospitals, and others.

Based on geography, the market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America held the largest market share of the coagulation market. North America accounts for a significant market share owing to the growing incidences of blood disorders, increasing occurrence of cardiovascular diseases such as atrial fibrillation (AFib), and the presence of major market players engaged in new and existing product developments. The US holds the largest share of the coagulation market in North America. The burgeoning cases of blood disorders, growing prevalence of cardiovascular diseases, and government support for preventing blood disorders are anticipated to boost the North America coagulation market growth during the forecast period. As per the Canadian Task Force on Preventive Health Care, the incidence of AFib in Canada increases by 4.5% per year, with a lifetime risk of ~25% among people aged more than 40 years. Approximately 300,000 Canadians carry an inherited bleeding disorder gene. 1 in 10 of these people—at least 30,000 Canadians—have symptoms severe enough to require medical care. Many of them have not been properly diagnosed. Only 10,000 people with inherited bleeding disorders are registered in the Canadian network of comprehensive care clinics for inherited bleeding disorders. According to the Canadian Hemophilia Society, ~300,000 Canadians carry a gene for an inherited blood disorder. Thus, the rising number of cases of congenital blood disorders can be associated with the growth of the coagulation market in Canada.

American Heart Association (AHA), Centers for Disease Control and Prevention (CDC), European Union, and Canadian Task Force on Preventive Health Care are a few key primary and secondary sources referred to while preparing the report on the coagulation market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

Year of Publication:

Clinical Laboratory Analyzers Segment, by Type to Account Larger Share in Coagulation Market during 2022–2030

According to our latest study on “Coagulation Market Forecast to 2030 –Global Analysis – Disease Indication, Type, Offering, Technology, and End User,” the market is expected to grow from US$ 6.295 billion in 2022 and is expected to reach US$ 10.853 billion by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030. The report highlights the key factors driving the coagulation market growth and prominent players with their developments in the market.

Coagulation or clotting is the process by which blood turns from a liquid into a gel and forms a blood clot. This potentially leads to hemostasis, which is the interruption of blood loss from a damaged vessel, followed by repair. Coagulation analyzer measures and evaluates the rate of clot formation or clot coagulation. It helps prevent the risk of heart attacks, embolism, and thrombosis by identifying the blood clots in the blood vessels. Obesity, heart attack, diabetes, and high blood pressure are diseases caused by lifestyle changes. Therefore, this device is a primary diagnostic tool for conditions like these. The demand for such devices in hospitals is increasing since it is a powerful automated device that serves as diagnostic tool for blood-related diseases.

Based on type, the coagulation market is bifurcated into clinical laboratory analyzers and point-of-care testing analyzers. Clinical laboratory analyzers are further categorized as controls & calibrators, assays & reagents, instruments/systems, coagulation factors, and others. The clinical laboratory analyzers segment held a larger share of the coagulation market in 2022. Further, the point-of-care testing analyzers segment is anticipated to register a higher CAGR from 2022 to 2030. Analyzers for point-of-care testing are used to measure the electrochemical, optical, and mechanical parameters of blood. Cutting-edge technologies, including microfluidics, fluorescent microscopy, electrochemical sensing, photoacoustic detection, and nano/micro electrochemical systems, are used to create extremely accurate, durable, and affordable point-of-care devices. Furthermore, the introduction of various point-of-care devices enabled by cutting-edge, precise, and reliable technologies helps low-volume and high-volume labs perform optical analyses of blood clotting parameters and automation. Therefore, such aforementioned factors are expected to boost the segment growth in forecast period.

Based on offering, the coagulation market is bifurcated into diagnosis and treatment. The diagnosis segment held a larger share of the market in 2022. Further, the treatment segment is anticipated to register a higher CAGR in the coagulation market during 2022–2030. The treatment segment is further classified into anti-fibrinolytic drugs, birth control pills, desmopressin and immunosuppressive medicines, vitamin K supplements, blood thinners, thrombin inhibitors or thrombolytics, replacement therapies, catheter-assisted thrombus removal, and others. Antifibrinolytics are medications that are used to stop excessive blood loss. They have been used for decades in patients undergoing certain dental or surgical procedures, and those who are susceptible to bleeding complications. Antifibrinolytics work by preventing fibrinolysis, the natural breakdown of blood clots. Anticoagulant medications, also known as blood thinners, are primarily used in the prevention and treatment of blood clots. Thrombin inhibitors are anticoagulants that inhibit the activity of thrombin by binding to it, subsequently preventing blood clot formation. In addition to preventing arterial and venous thrombosis, these medications can also be used to prevent and treat deep vein thrombosis. Thus, the segment is expected to grow due to the benefits offered by the various treatment methods for coagulation during the forecast period.

NORDIC BIOMARKER; ImproGen Diagnostik Kimya San. & Tic. Ltd.; Diagnostica Stago, Inc.; Siemens Healthcare Private Limited; Sysmex; Helena Biosciences; F. Hoffmann-La Roche Ltd; Genrui Biotech Co., Ltd.; Transasia Bio-Medicals; HORIBA Medical are among the leading companies operating in the global coagulation market.

Companies operating in the coagulation market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the coagulation market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall coagulation market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.

• In July 2022, HORIBA Medical adds extra pre-analytical functionality to its fully automated hemostasis analyzer Yumizen G800. The new Tube Filling Level Check option for the Yumizen G800 helps to overcome a significant pre-analytical error risk factor.

• In August 2021, Siemens Healthineers Launched Sysmex CN-3000 and CN-6000 Hemostasis Systems. This fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories.

• In February 2021, Siemens Healthineers and Sysmex Extend Hemostasis renewed their long-standing agreement of global supply, distributorship, sales, and service for a broad portfolio of hemostasis products including a multi-year extension. As part of the agreement Siemens Healthineers agreed to distribute the new Sysmex CN Systems.

• In July 2020, Sysmex Launched Automated Blood Coagulation Analyzers CN-6500 and CN-3500 in Japan and EMEA. These integrated analyzers incorporate features of their predecessors the CN-6000/CN-3000, such as high levels of productivity, reliability, operability, and serviceability, and come with a measuring unit using CLEIA, a measuring principle developed with HISCL. It allow for flexible measurements in response to a broad range of test orders in the fields of thrombosis and hemostasis.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the coagulation market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the coagulation market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth market trends and outlook coupled with the factors driving the coagulation market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Coagulation Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Coagulation Market – Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Market Drivers
5.1.2 Increasing Prevalence of Blood Disorders
5.1.3 Rising Prevalence of Cardiovascular Diseases
5.2 Market Restraints
5.2.1 High Costs Associated with Coagulation Analyzers
5.3 Market Opportunities
5.3.1 Growing Organic and Inorganic Strategies by Key Market Players
5.4 Future Trends
5.4.1 Development of Point-of-Care (POC) Coagulation Analyzers
5.5 Impact Analysis
6. Coagulation Market – Global Market Analysis
6.1 Coagulation Market Revenue (US$ million), 2022 – 2030
6.2 Geography Analysis Market Revenue (US$ million), 2022 – 2030
7. Global Coagulation Market – Revenue and Forecast to 2030 – by Disease Indication
7.1 Overview
7.2 Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
7.3 Vitamin K Deficiency
7.3.1 Overview
7.3.2 Vitamin K Deficiency: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Liver Disease
7.4.1 Overview
7.4.2 Liver Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Disseminated Intravascular Coagulation and Pulmonary Embolism
7.5.1 Overview
7.5.2 Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Development of Circulating Anticoagulant
7.6.1 Overview
7.6.2 Development of Circulating Anticoagulant: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Hemophilia
7.7.1 Overview
7.7.2 Hemophilia: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Von Willebrand’s Disease
7.8.1 Overview
7.8.2 Von Willebrand’s Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Coagulation Market – Revenue and Forecast to 2030 – by Type
8.1 Overview
8.2 Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
8.3 Clinical Laboratory Analyzers
8.3.1 Overview
8.3.2 Clinical Laboratory Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Global Coagulation Market, by Clinical Laboratory Analyzers
8.4 Point-of-Care Testing Analyzers
8.4.1 Overview
8.4.2 Point-of-Care Testing Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Coagulation Market – Revenue and Forecast to 2030 – by Offering
9.1 Overview
9.2 Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
9.3 Diagnosis
9.3.1 Overview
9.3.2 Diagnosis: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.3.2.1 Global Coagulation Market, by Diagnosis
9.4 Treatment
9.4.1 Overview
9.4.2 Treatment: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
9.4.2.1 Global Coagulation Market, by Treatment
10. Global Coagulation Market – Revenue and Forecast to 2030 – by Technology
10.1 Overview
10.2 Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
10.3 Optical Technology
10.3.1 Overview
10.3.2 Optical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Mechanical Technology
10.4.1 Overview
10.4.2 Mechanical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Electrochemical Technology
10.5.1 Overview
10.5.2 Electrochemical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11. Global Coagulation Market – Revenue and Forecast to 2030 – by End User
11.1 Overview
11.2 Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
11.3 Clinical Laboratories
11.3.1 Overview
11.3.2 Clinical Laboratories: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11.4 Hospitals
11.4.1 Overview
11.4.2 Hospitals: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
12. Coagulation Market – Geographical Analysis
12.1 North America Coagulation Market, Revenue And Forecast To 2030
12.1.1 Overview
12.1.2 North America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.3 North America Coagulation Market, by Disease Indication
12.1.4 North America Coagulation Market, by Type
12.1.4.1 North America Coagulation Market, by Clinical Laboratory Analyzers
12.1.5 North America Coagulation Market, by Offering
12.1.5.1 North America Coagulation Market, by Diagnosis
12.1.5.2 North America Coagulation Market, by Treatment
12.1.6 North America Coagulation Market, by Technology
12.1.7 North America Coagulation Market, by End User
12.1.7.1 North America Coagulation Market, by Country
12.1.7.2 US
12.1.7.2.1 Overview
12.1.7.2.2 US Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.2.3 US Coagulation Market, by Disease Indication
12.1.7.2.4 US Coagulation Market, by Type
12.1.7.2.4.1 US Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.2.5 US Coagulation Market, by Offering
12.1.7.2.5.1 US Coagulation Market, by Diagnosis
12.1.7.2.5.2 US Coagulation Market, by Treatment
12.1.7.2.6 US Coagulation Market, by Technology
12.1.7.2.7 US Coagulation Market, by End User
12.1.7.3 Canada
12.1.7.3.1 Overview
12.1.7.3.2 Canada Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.3.3 Canada Coagulation Market, by Disease Indication
12.1.7.3.4 Canada Coagulation Market, by Type
12.1.7.3.4.1 Canada Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.3.5 Canada Coagulation Market, by Offering
12.1.7.3.5.1 Canada Coagulation Market, by Diagnosis
12.1.7.3.5.2 Canada Coagulation Market, by Treatment
12.1.7.3.6 Canada Coagulation Market, by Technology
12.1.7.3.7 Canada Coagulation Market, by End User
12.1.7.4 Mexico
12.1.7.4.1 Overview
12.1.7.4.2 Mexico Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.1.7.4.3 Mexico Coagulation Market, by Disease Indication
12.1.7.4.4 Mexico Coagulation Market, by Type
12.1.7.4.4.1 Mexico Coagulation Market, by Clinical Laboratory Analyzers
12.1.7.4.5 Mexico Coagulation Market, by Offering
12.1.7.4.5.1 Mexico Coagulation Market, by Diagnosis
12.1.7.4.5.2 US Coagulation Market, by Treatment
12.1.7.4.6 Mexico Coagulation Market, by Technology
12.1.7.4.7 Mexico Coagulation Market, by End User
12.2 Europe Coagulation Market, Revenue And Forecast to 2030
12.2.1 Overview
12.2.2 Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.3 Europe Coagulation Market, by Disease Indication
12.2.4 Europe Coagulation Market, by Type
12.2.4.1 Europe Coagulation Market, by Clinical Laboratory Analyzers
12.2.5 Europe Coagulation Market, by Offering
12.2.5.1 Europe Coagulation Market, by Diagnosis
12.2.5.2 Europe Coagulation Market, by Treatment
12.2.6 Europe Coagulation Market, by Technology
12.2.7 Europe Coagulation Market, by End User
12.2.8 Europe Coagulation Market by Country
12.2.8.1 Germany
12.2.8.1.1 Overview
12.2.8.1.2 Germany Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.1.3 Germany Coagulation Market, by Disease Indication
12.2.8.1.4 Germany Coagulation Market, by Type
12.2.8.1.4.1 Germany Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.1.5 Germany Coagulation Market, by Offering
12.2.8.1.5.1 Germany Coagulation Market, by Diagnosis
12.2.8.1.5.2 Germany Coagulation Market, by Treatment
12.2.8.1.6 Germany Coagulation Market, by Technology
12.2.8.1.7 Germany Coagulation Market, by End User
12.2.8.2 UK
12.2.8.2.1 Overview
12.2.8.2.1.1 UK Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.2.2 UK Coagulation Market, by Disease Indication
12.2.8.2.3 UK Coagulation Market, by Type
12.2.8.2.3.1 UK Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.2.4 UK Coagulation Market, by Offering
12.2.8.2.4.1 UK Coagulation Market, by Diagnosis
12.2.8.2.4.2 UK Coagulation Market, by Treatment
12.2.8.2.5 UK Coagulation Market, by Technology
12.2.8.2.6 UK Coagulation Market, by End User
12.2.8.3 France
12.2.8.3.1 Overview
12.2.8.3.1.1 France Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.3.2 France Coagulation Market, by Disease Indication
12.2.8.3.3 France Coagulation Market, by Type
12.2.8.3.3.1 France Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.3.4 France Coagulation Market, by Offering
12.2.8.3.4.1 France Coagulation Market, by Diagnosis
12.2.8.3.4.2 France Coagulation Market, by Treatment
12.2.8.3.5 France Coagulation Market, by Technology
12.2.8.3.6 France Coagulation Market, by End User
12.2.8.4 Italy
12.2.8.4.1 Overview
12.2.8.4.1.1 Italy Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.4.2 Italy Coagulation Market, by Disease Indication
12.2.8.4.3 Italy Coagulation Market, by Type
12.2.8.4.3.1 Italy Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.4.4 Italy Coagulation Market, by Offering
12.2.8.4.4.1 Italy Coagulation Market, by Diagnosis
12.2.8.4.4.2 Italy Coagulation Market, by Treatment
12.2.8.4.5 Italy Coagulation Market, by Technology
12.2.8.4.6 Italy Coagulation Market, by End User
12.2.8.5 Spain
12.2.8.5.1 Overview
12.2.8.5.2 Spain Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.5.3 Spain Coagulation Market, by Disease Indication
12.2.8.5.4 Spain Coagulation Market, by Type
12.2.8.5.4.1 Spain Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.5.5 Spain Coagulation Market, by Offering
12.2.8.5.5.1 Spain Coagulation Market, by Diagnosis
12.2.8.5.5.2 Spain Coagulation Market, by Treatment
12.2.8.5.6 Spain Coagulation Market, by Technology
12.2.8.5.7 Spain Coagulation Market, by End User
12.2.8.6 Rest of Europe
12.2.8.6.1 Overview
12.2.8.6.2 Rest of Europe Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.2.8.6.3 Rest of Europe Coagulation Market, by Disease Indication
12.2.8.6.4 Rest of Europe Coagulation Market, by Type
12.2.8.6.4.1 Rest of Europe Coagulation Market, by Clinical Laboratory Analyzers
12.2.8.6.5 Rest of Europe Coagulation Market, by Offering
12.2.8.6.5.1 Rest of Europe Coagulation Market, by Diagnosis
12.2.8.6.5.2 Rest of Europe Coagulation Market, by Treatment
12.2.8.6.6 Rest of Europe Coagulation Market, by Technology
12.2.8.6.7 Rest of Europe Coagulation Market, by End User
12.3 Asia Pacific Coagulation Market, Revenue and Forecast to 2030
12.3.1 Overview
12.3.2 Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.3 Asia Pacific Coagulation Market, by Disease Indication
12.3.4 Asia Pacific Coagulation Market, by Type
12.3.4.1 Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
12.3.5 Asia Pacific Coagulation Market, by Offering
12.3.5.1 Asia Pacific Coagulation Market, by Diagnosis
12.3.5.2 Asia Pacific Coagulation Market, by Treatment
12.3.6 Asia Pacific Coagulation Market, by Technology
12.3.7 Asia Pacific Coagulation Market, by End User
12.3.8 Asia Pacific Coagulation Market by Country
12.3.8.1 China
12.3.8.1.1 Overview
12.3.8.1.2 China Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.1.3 China Coagulation Market, by Disease Indication
12.3.8.1.4 China Coagulation Market, by Type
12.3.8.1.4.1 China Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.1.5 China Coagulation Market, by Offering
12.3.8.1.5.1 China Coagulation Market, by Diagnosis
12.3.8.1.5.2 China Coagulation Market, by Treatment
12.3.8.1.6 China Coagulation Market, by Technology
12.3.8.1.7 China Coagulation Market, by End User
12.3.8.2 Japan
12.3.8.2.1 Overview
12.3.8.2.2 Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.2.3 Japan Coagulation Market, by Disease Indication
12.3.8.2.4 Japan Coagulation Market, by Type
12.3.8.2.4.1 Japan Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.2.5 Japan Coagulation Market, by Offering
12.3.8.2.5.1 Japan Coagulation Market, by Diagnosis
12.3.8.2.5.2 Japan Coagulation Market, by Treatment
12.3.8.2.6 Japan Coagulation Market, by Technology
12.3.8.2.7 Japan Coagulation Market, by End User
12.3.8.3 India
12.3.8.3.1 Overview
12.3.8.3.2 India Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.3.3 India Coagulation Market, by Disease Indication
12.3.8.3.4 India Coagulation Market, by Type
12.3.8.3.4.1 India Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.3.5 India Coagulation Market, by Offering
12.3.8.3.5.1 India Coagulation Market, by Diagnosis
12.3.8.3.5.2 India Coagulation Market, by Treatment
12.3.8.3.6 India Coagulation Market, by Technology
12.3.8.3.7 India Coagulation Market, by End User
12.3.8.4 Australia
12.3.8.4.1 Overview
12.3.8.4.2 Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.4.3 Australia Coagulation Market, by Disease Indication
12.3.8.4.4 Australia Coagulation Market, by Type
12.3.8.4.4.1 Australia Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.4.5 Australia Coagulation Market, by Offering
12.3.8.4.5.1 Australia Coagulation Market, by Diagnosis
12.3.8.4.5.2 Australia Coagulation Market, by Treatment
12.3.8.4.6 Australia Coagulation Market, by Technology
12.3.8.4.7 Australia Coagulation Market, by End User
12.3.8.5 South Korea
12.3.8.5.1 Overview
12.3.8.5.2 South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.5.3 South Korea Coagulation Market, by Disease Indication
12.3.8.5.4 South Korea Coagulation Market, by Type
12.3.8.5.4.1 South Korea Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.5.5 South Korea Coagulation Market, by Offering
12.3.8.5.5.1 South Korea Coagulation Market, by Diagnosis
12.3.8.5.5.2 South Korea Coagulation Market, by Treatment
12.3.8.5.6 South Korea Coagulation Market, by Technology
12.3.8.5.7 South Korea Coagulation Market, by End User
12.3.8.6 Rest of Asia Pacific
12.3.8.6.1 Overview
12.3.8.6.2 Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.3.8.6.3 Rest of Asia Pacific Coagulation Market, by Disease Indication
12.3.8.6.4 Rest of Asia Pacific Coagulation Market, by Type
12.3.8.6.4.1 Rest of Asia Pacific Coagulation Market, by Clinical Laboratory Analyzer
12.3.8.6.5 Rest of Asia Pacific Coagulation Market, by Offering
12.3.8.6.5.1 Rest of Asia Pacific Coagulation Market, by Diagnosis
12.3.8.6.5.2 Rest of Asia Pacific Coagulation Market, by Treatment
12.3.8.6.6 Rest of Asia Pacific Coagulation Market, by Technology
12.3.8.6.7 Rest of Asia Pacific Coagulation Market, by End User
12.4 Middle East & Africa Coagulation Market, Revenue and Forecast to 2030
12.4.1 Overview
12.4.2 Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.3 Middle East & Africa Coagulation Market, by Disease Indication
12.4.4 Middle East & Africa Coagulation Market, by Type
12.4.4.1 Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.5 Middle East & Africa Coagulation Market, by Offering
12.4.5.1 Middle East & Africa Coagulation Market, by Diagnosis
12.4.5.2 Middle East & Africa Coagulation Market, by Treatment
12.4.6 Middle East & Africa Coagulation Market, by Technology
12.4.7 Middle East & Africa Coagulation Market, by End User
12.4.7.1 Middle East & Africa Coagulation Market by Country
12.4.7.2 Saudi Arabia
12.4.7.2.1 Overview
12.4.7.2.2 Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.2.3 Saudi Arabia Coagulation Market, by Disease Indication
12.4.7.2.4 Saudi Arabia Coagulation Market, by Type
12.4.7.2.4.1 Saudi Arabia Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.2.5 Saudi Arabia Coagulation Market, by Offering
12.4.7.2.5.1 Saudi Arabia Coagulation Market, by Diagnosis
12.4.7.2.5.2 Saudi Arabia Coagulation Market, by Treatment
12.4.7.2.6 Saudi Arabia Coagulation Market, by Technology
12.4.7.2.7 Saudi Arabia Coagulation Market, by End User
12.4.7.3 South Africa
12.4.7.3.1 Overview
12.4.7.3.2 South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.3.3 South Africa Coagulation Market, by Disease Indication
12.4.7.3.4 South Africa Coagulation Market, by Type
12.4.7.3.4.1 South Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.3.5 South Africa Coagulation Market, by Offering
12.4.7.3.5.1 South Africa Coagulation Market, by Diagnosis
12.4.7.3.5.2 South Africa Coagulation Market, by Treatment
12.4.7.3.6 South Africa Coagulation Market, by Technology
12.4.7.3.7 South Africa Coagulation Market, by End User
12.4.7.4 UAE
12.4.7.4.1 Overview
12.4.7.4.2 UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.4.3 UAE Coagulation Market, by Disease Indication
12.4.7.4.4 UAE Coagulation Market, by Type
12.4.7.4.4.1 UAE Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.4.5 UAE Coagulation Market, by Offering
12.4.7.4.5.1 UAE Coagulation Market, by Diagnosis
12.4.7.4.5.2 UAE Coagulation Market, by Treatment
12.4.7.4.6 UAE Coagulation Market, by Technology
12.4.7.4.7 UAE Coagulation Market, by End User
12.4.7.5 Rest of Middle East & Africa
12.4.7.5.1 Overview
12.4.7.5.2 Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.4.7.5.3 Rest of Middle East & Africa Coagulation Market, by Disease Indication
12.4.7.5.4 Rest of Middle East & Africa Coagulation Market, by Type
12.4.7.5.4.1 Rest of Middle East & Africa Coagulation Market, by Clinical Laboratory Analyzer
12.4.7.5.5 Rest of Middle East & Africa Coagulation Market, by Offering
12.4.7.5.5.1 Rest of Middle East & Africa Coagulation Market, by Diagnosis
12.4.7.5.5.2 Rest of Middle East & Africa Coagulation Market, by Treatment
12.4.7.5.6 Rest of Middle East & Africa Coagulation Market, by Technology
12.4.7.5.7 Rest of Middle East & Africa Coagulation Market, by End User
12.5 South & Central America Coagulation Market, Revenue and Forecast to 2030
12.5.1 Overview
12.5.2 South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.3 South & Central America Coagulation Market, by Disease Indication
12.5.4 South & Central America Coagulation Market, by Type
12.5.4.1 South & Central America Coagulation Market, by Clinical Laboratory Analyzer
12.5.5 South & Central America Coagulation Market, by Offering
12.5.5.1 South & Central America Coagulation Market, by Diagnosis
12.5.5.2 South & Central America Coagulation Market, by Treatment
12.5.6 South & Central America Coagulation Market, by Technology
12.5.7 South & Central America Coagulation Market, by End User
12.5.8 South & Central America Coagulation Market by Country
12.5.8.1 Brazil
12.5.8.1.1 Overview
12.5.8.1.2 Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.1.3 Brazil Coagulation Market, by Disease Indication
12.5.8.1.4 Brazil Coagulation Market, by Type
12.5.8.1.4.1 Brazil Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.1.5 Brazil Coagulation Market, by Offering
12.5.8.1.5.1 Brazil Coagulation Market, by Diagnosis
12.5.8.1.5.2 Brazil Coagulation Market, by Treatment
12.5.8.1.6 Brazil Coagulation Market, by Technology
12.5.8.1.7 Brazil Coagulation Market, by End User
12.5.8.2 Argentina
12.5.8.2.1 Overview
12.5.8.2.2 Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.2.3 Argentina Coagulation Market, by Disease Indication
12.5.8.2.4 Argentina Coagulation Market, by Type
12.5.8.2.4.1 Argentina Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.2.5 Argentina Coagulation Market, by Offering
12.5.8.2.5.1 Argentina Coagulation Market, by Diagnosis
12.5.8.2.5.2 Argentina Coagulation Market, by Treatment
12.5.8.2.6 Argentina Coagulation Market, by Technology
12.5.8.2.7 Argentina Coagulation Market, by End User
12.5.8.3 Rest of South & Central America
12.5.8.3.1 Overview
12.5.8.3.2 Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
12.5.8.3.3 Rest of South & Central America Coagulation Market, by Disease Indication
12.5.8.3.4 Rest of South & Central America Coagulation Market, by Type
12.5.8.3.4.1 Rest of South & Central America Coagulation Market, by Clinical Laboratory Analyzer
12.5.8.3.5 Rest of South & Central America Coagulation Market, by Offering
12.5.8.3.5.1 Rest of South & Central America Coagulation Market, by Diagnosis
12.5.8.3.5.2 Rest of South & Central America Coagulation Market, by Treatment
12.5.8.3.6 Rest of South & Central America Coagulation Market, by Technology
12.5.8.3.7 Rest of South & Central America Coagulation Market, by End User
13. Coagulation Market–Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Coagulation Market
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Siemens Healthineers AG
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Diagnostica Stago, Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 ImproGen Diagnostik Kimya San. & Tic. Ltd.?ti.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Nordic Biomarker AB
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sysmex Corp
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Helena Laboratories Corporation
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 F. Hoffmann-La Roche Ltd
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Genrui Biotech Co., Ltd.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Transasia Bio-Medicals Ltd
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Horiba Ltd.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms

LIST OF TABLES

Table 1. Coagulation Market Segmentation
Table 2. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 3. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 4. Global Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 5. Optical Technologies and Their Applications
Table 6. Mechanical Technologies and Their Applications
Table 7. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 8. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 9. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 10. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 11. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 12. North America Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 13. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 14. North America Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 15. US Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 16. US Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 17. US Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 18. US Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 19. US Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 20. US Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 21. US Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 22. US Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 23. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 24. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 25. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 26. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 27. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 28. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 29. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 30. Canada Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 31. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 32. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 33. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 34. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 35. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 36. US Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 37. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 38. Mexico Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 39. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 40. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 41. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 42. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 43. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 44. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 45. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 46. Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 47. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 48. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 49. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 50. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 51. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 52. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 53. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 54. Germany Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 55. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 56. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 57. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 58. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 59. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 60. UK Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 61. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 62. UK Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 63. France Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 64. France Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 65. France Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 66. France Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 67. France Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 68. France Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 69. France Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 70. France Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 71. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 72. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 73. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 74. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 75. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 76. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 77. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 78. Italy Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 79. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 80. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 81. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 82. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 83. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 84. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 85. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 86. Spain Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 87. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Disease Indication
Table 88. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Type
Table 89. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Clinical Laboratory Analyzers
Table 90. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) – Offering
Table 91. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Diagnosis
Table 92. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million) – Treatment
Table 93. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) – Technology
Table 94. Rest of Europe Coagulation Market Revenue And Forecast To 2030 (US$ million) – End User
Table 95. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 96. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 97. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 98. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 99. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 100. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 101. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 102. Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 103. China Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 104. China Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 105. China Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 106. China Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 107. China Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 108. China Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 109. China Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 110. China Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 111. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 112. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 113. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 114. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 115. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 116. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 117. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 118. Japan Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 119. India Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 120. India Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 121. India Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 122. India Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 123. India Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 124. India Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 125. India Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 126. India Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 127. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 128. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 129. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 130. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 131. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 132. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 133. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 134. Australia Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 135. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 136. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 137. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 138. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 139. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 140. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 141. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 142. South Korea Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 143. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 144. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 145. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 146. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 147. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 148. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 149. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 150. Rest of Asia Pacific Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 151. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 152. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 153. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 154. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 155. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 156. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 157. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 158. Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 159. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 160. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 161. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 162. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 163. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 164. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 165. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 166. Saudi Arabia Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 167. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 168. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 169. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 170. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 171. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 172. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 173. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 174. South Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 175. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 176. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 177. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 178. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 179. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 180. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 181. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 182. UAE Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 183. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 184. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 185. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 186. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 187. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 188. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 189. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 190. Rest of Middle East & Africa Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 191. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 192. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 193. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 194. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 195. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 196. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 197. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 198. South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 199. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 200. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 201. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 202. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 203. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 204. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 205. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 206. Brazil Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 207. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 208. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 209. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 210. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 211. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 212. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 213. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 214. Argentina Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 215. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Disease Indication
Table 216. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Type
Table 217. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Clinical Laboratory Analyzer
Table 218. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – Offering
Table 219. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Diagnosis
Table 220. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million) – Treatment
Table 221. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – Technology
Table 222. Rest of South & Central America Coagulation Market Revenue and Forecast To 2030 (US$ million) – End User
Table 223. Recent Inorganic Growth Strategies in the Coagulation Market
Table 224. Recent Organic Growth Strategies in the Coagulation Market
Table 225. Glossary of Terms, Coagulation Market

LIST OF FIGURES

Figure 1. Coagulation Market Segmentation, By Geography
Figure 2. North America – PEST Analysis
Figure 3. Coagulation Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Coagulation Market Revenue (US$ million), 2020 – 2030
Figure 6. Geography Analysis Market Revenue (US$ million), 2022 – 2030
Figure 7. Coagulation Market Revenue Share, by Disease Indication 2022 & 2030 (%)
Figure 8. Vitamin K Deficiency: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Liver Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Disseminated Intravascular Coagulation and Pulmonary Embolism: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Development of Circulating Anticoagulant: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Hemophilia: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Von Willebrand’s Disease: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Coagulation Market Revenue Share, by Type 2022 & 2030 (%)
Figure 16. Clinical Laboratory Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Point-of-Care Testing Analyzers: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Coagulation Market Revenue Share, by Offering 2022 & 2030 (%)
Figure 19. Diagnosis: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Treatment: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Coagulation Market Revenue Share, by Technology 2022 & 2030 (%)
Figure 22. Optical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Mechanical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Electrochemical Technology: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Coagulation Market Revenue Share, by End User 2022 & 2030 (%)
Figure 27. Clinical Laboratories: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Hospitals: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Others: Coagulation Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Coagulation Market, 2022 ($million)
Figure 31. North America Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 32. North America Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 33. US Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 34. Canada Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 35. Mexico Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 36. Europe Coagulation Market, By Geography, 2022 ($million)
Figure 37. Europe Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 38. Europe Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 39. Germany Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 40. UK Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 41. France Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 42. Italy Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 43. Spain Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 44. Rest of Europe Coagulation Market Revenue And Forecast to 2030 (US$ million)
Figure 45. Coagulation Market, By Geography, 2022 (US$ Million)
Figure 46. Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 47. Asia Pacific Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 48. China Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 49. Japan Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 50. India Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 51. Australia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 52. South Korea Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 53. Rest of Asia Pacific Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 54. Coagulation Market, By Geography, 2022 And 2030 ($million)
Figure 55. Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 56. Middle East & Africa Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 57. Saudi Arabia Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 58. South Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 59. UAE Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 60. Rest of Middle East & Africa Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 61. Coagulation Market, By Geography, 2022 ($million)
Figure 62. South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 63. South & Central America Coagulation Market, By Key Countries, 2022 And 2030 (%)
Figure 64. Brazil Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 65. Argentina Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 66. Rest of South & Central America Coagulation Market Revenue and Forecast to 2030 (US$ million)
Figure 67. Growth Strategies in the Coagulation Market

The List of Companies – Coagulation Market
o NORDIC BIOMARKER
o ImproGen Diagnostik Kimya San. & Tic. Ltd.
o Diagnostica Stago, Inc.
o Siemens Healthcare Private Limited
o Sysmex
o Helena Biosciences
o F. Hoffmann-La Roche Ltd
o Genrui Biotech Co., Ltd.
o Transasia Bio-Medicals
o HORIBA Medical

Reviews

There are no reviews yet.

Be the first to review “Coagulation Market Size and Forecasts (2020-2030)”